Bydureon and Valtrex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bydureon (exenatide synthetic) and Valtrex (valacyclovir hydrochloride). Common drug interactions include swelling face among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Bydureon and Valtrex. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Bydureon?

Bydureon has active ingredients of exenatide synthetic. It is often used in type 2 diabetes. eHealthMe is studying from 24,309 Bydureon users. Check the latest studies of Bydureon.

What is Valtrex?

Valtrex has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 39,999 Valtrex users. Check the latest studies of Valtrex.



On Jul, 30, 2026

32 people who take Bydureon and Valtrex together, and have interactions are studied.

Bydureon and Valtrex drug interactions.

What are the common drug interactions of Bydureon and Valtrex, by gender? *:

female:

  1. Swelling face
  2. Swollen tongue (swelling of tongue)
  3. Hypokalaemia (low potassium)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Decreased appetite
  6. Nausea (feeling of having an urge to vomit)
  7. Weight decreased
  8. Blood pressure increased
  9. Bone cyst
  10. Dysstasia (difficulty in standing)

male:

  1. Chronic kidney disease
  2. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  3. Bone density decreased
  4. Blood glucose increased
  5. Death
  6. Fatigue (feeling of tiredness)
  7. Injection site haemorrhage (bleeding from injection site)
  8. Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site)
  9. Injection site pain
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

What are the common drug interactions of Bydureon and Valtrex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Swelling face
  3. Swollen tongue (swelling of tongue)

40-49:

  1. Chronic kidney disease
  2. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Bone pain
  6. Drug resistance (reduction in effectiveness of a drug)
  7. Emotional distress
  8. Gait disturbance
  9. Pain
  10. Renal impairment (severely reduced kidney function)

50-59:

  1. Hypokalaemia (low potassium)
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Decreased appetite
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Nausea (feeling of having an urge to vomit)
  6. Pleurisy (inflammation of the pleurae, which causes pain when breathing)
  7. Blood pressure increased
  8. Arthralgia (joint pain)
  9. Blood potassium decreased
  10. Blood sodium decreased

60+:

  1. Acute left ventricular failure (heart attack)
  2. Blood glucose increased
  3. Drug effect decreased
  4. Drug ineffective
  5. Dyspnoea (difficult or laboured respiration)
  6. Dysstasia (difficulty in standing)
  7. Fibromyalgia (a long-term condition which causes pain all over the body)
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Hypertensive heart disease
  10. Muscular weakness (muscle weakness)

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 11 people, 34.38%
  2. Diabetes: 11 people, 34.38%
  3. High Blood Pressure: 9 people, 28.12%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 21.88%
  5. Depression: 7 people, 21.88%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 7 people, 21.88%
  7. Hypersensitivity: 6 people, 18.75%
  8. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 5 people, 15.62%
  9. Pain: 5 people, 15.62%
  10. Itching: 5 people, 15.62%

* Approximation only. Some reports may have incomplete information.

Do you take Bydureon and Valtrex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bydureon and Valtrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bydureon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valtrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bydureon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valtrex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on exenatide synthetic and valacyclovir hydrochloride (the active ingredients of Bydureon and Valtrex, respectively), and Bydureon and Valtrex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: